HSF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.242200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.376200E-01
Normal-vs-Stage2
9.615600E-03
Normal-vs-Stage3
6.779600E-03
Normal-vs-Stage4
5.196500E-02
Stage1-vs-Stage2
3.633600E-01
Stage1-vs-Stage3
1.393640E-01
Stage1-vs-Stage4
7.084800E-01
Stage2-vs-Stage3
2.128600E-01
Stage2-vs-Stage4
8.392200E-01
Stage3-vs-Stage4
6.565900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.250000E-02
Normal-vs-AfricanAmerican
6.108500E-02
Normal-vs-Asian
4.496600E-03
Caucasian-vs-AfricanAmerican
5.535200E-01
Caucasian-vs-Asian
1.625180E-01
AfricanAmerican-vs-Asian
5.511800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.781600E-02
Normal-vs-Female
4.807800E-02
Male-vs-Female
4.195000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.983900E-02
Normal-vs-Age(41-60Yrs)
6.419900E-02
Normal-vs-Age(61-80Yrs)
3.558400E-02
Normal-vs-Age(81-100Yrs)
2.061900E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.479200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.757800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.942200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.063430E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.398220E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.430800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.302500E-03
Normal-vs-Daily Drinker
3.738700E-03
Normal-vs-Weekly Drinker
4.380000E-02
Normal-vs-Occasional Drinker
2.437000E-01
Normal-vs-Social Drinker
2.543000E-01
Non Drinker-vs-Daily Drinker
9.418000E-01
Non Drinker-vs-Weekly Drinker
2.348000E-01
Non Drinker-vs-Occasional Drinker
1.614560E-01
Non Drinker-vs-Social Drinker
1.569990E-01
Daily Drinker-vs-Weekly Drinker
2.673400E-01
Daily Drinker-vs-Occasional Drinker
1.637440E-01
Daily Drinker-vs-Social Drinker
1.574840E-01
Weekly Drinker-vs-Occasional Drinker
6.228400E-01
Weekly Drinker-vs-Social Drinker
5.605400E-01
Occasional Drinker-vs-Social Drinker
9.351000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.890400E-01
Normal-vs-Grade 2
9.864600E-01
Normal-vs-Grade 3
9.413000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.190600E-01
Grade 1-vs-Grade 3
9.013900E-02
Grade 1-vs-Grade 4
7.890400E-01
Grade 2-vs-Grade 3
3.093200E-01
Grade 2-vs-Grade 4
9.864600E-01
Grade 3-vs-Grade 4
9.413000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.209700E-02
Normal-vs-NonDiabetic
2.496000E-02
Diabetic-vs-NonDiabetic
7.993600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.484300E-02
Normal-vs-NoPancreatitis
2.771600E-02
Pancreatitis-vs-NoPancreatitis
9.565600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.254170E-01
Normal-vs-N1
9.461800E-03
N0-vs-N1
2.425000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.379700E-03
Normal-vs-TP53-NonMutant
2.303200E-01
TP53-Mutant-vs-TP53-NonMutant
3.640000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
